Retatrutide
Triple-receptor research compound. GLP-1 / GIP / glucagon pathway investigation.
RESTRICTED ACCESS
All products on this site are research chemicals sold strictly for laboratory and analytical purposes. Not for human or animal consumption. Confirm the following to enter.
I do not agree, exitMETABOLIC & GLP-1
High-dose dual GLP-1 / GIP receptor agonist research peptide.
ABOUT THIS COMPOUND
The 60 mg presentation of Tirzepatide provides double the working volume per vial, intended for higher-throughput research protocols and extended study arms. Same molecule, same chain of custody.
Tirzepatide engages both the GLP-1 and GIP receptors and remains one of the most-studied dual-agonist research compounds in modern endocrinology. HPLC-verified, lyophilized, sealed under inert atmosphere.
SPECIFICATIONS
RESEARCH APPLICATIONS
All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.
QUALITY ASSURANCE
A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →
YOU MAY ALSO RESEARCH
QUESTIONS?
Lot questions, COA requests, institutional accounts, reach the team directly.
CONTACT US